Yantai Dongcheng Biochemicals Co., Ltd. engages in the research, development, production and sales of heparin sodium bulk drug and chondroitin sulfate. The company main product series include API, Preparation and Nuclide Drug Series. It manufactures active pharmaceutical ingredient, nuclear medicine, chemical synthetic drugs and modern Chinese medicines. The company’s products include heparin, chondroitin sulphate, marine collagen, hyaluronic acid, glucosamine, heparinoid and cytochrome C. Yantai Dongcheng Biochemicals was founded on December 31, 1998 and is headquartered in Yantai, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company